These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1969668)

  • 1. Dopamine D-1 and D-2 receptors in relation to reward and performance: a case for the D-1 receptor as a primary site of therapeutic action of neuroleptic drugs.
    Miller R; Wickens JR; Beninger RJ
    Prog Neurobiol; 1990; 34(2):143-83. PubMed ID: 1969668
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuroleptic drugs and their action on different neuronal pathways.
    Ungerstedt U; Herrera-Marschitz M; Forster C
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):34-7. PubMed ID: 2858478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine receptor pharmacology.
    Seeman P; Van Tol HH
    Curr Opin Neurol Neurosurg; 1993 Aug; 6(4):602-8. PubMed ID: 8104554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacology of catecholamine involvement in the neural mechanisms of reward.
    Wauquier A
    Acta Neurobiol Exp (Wars); 1980; 40(3):665-86. PubMed ID: 6108051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dopamine D1 receptor: biochemical and behavioral aspects.
    Andersen PH; Nielsen EB
    Adv Exp Med Biol; 1986; 204():73-91. PubMed ID: 2878580
    [No Abstract]   [Full Text] [Related]  

  • 6. Dopamine receptor mechanisms: behavioral and electrophysiological studies.
    Ungerstedt U; Ljungberg T; Schultz W
    Adv Biochem Psychopharmacol; 1978; 19():311-21. PubMed ID: 29451
    [No Abstract]   [Full Text] [Related]  

  • 7. Behavioural differentiation between effects elicited at dopamine D-1 and D-2 receptors in rats.
    Arnt J; Hyttel J
    Clin Neuropharmacol; 1986; 9 Suppl 4():17-9. PubMed ID: 2952268
    [No Abstract]   [Full Text] [Related]  

  • 8. Receptor pharmacology. Its use in neuroleptic research.
    Hyttel J
    Acta Psychiatr Belg; 1987; 87(5):535-51. PubMed ID: 2897759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical and behavioral studies of D1 dopamine receptors utilizing SCH 23390.
    Hess EJ; Creese I
    Psychopharmacol Bull; 1986; 22(3):605-12. PubMed ID: 2879304
    [No Abstract]   [Full Text] [Related]  

  • 10. The differential coupling mechanism of dopamine D-2 receptor subtypes: importance for the actions of neuroleptic drugs.
    Memo M; Missale C; Pizzi M; Spano PF
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():458A-459A. PubMed ID: 1354049
    [No Abstract]   [Full Text] [Related]  

  • 11. Chronic neuroleptic treatment increases D-2 but not D-1 receptors in rat striatum.
    MacKenzie RG; Zigmond MJ
    Eur J Pharmacol; 1985 Jul; 113(2):159-65. PubMed ID: 2864265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine receptor sequences. Therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4.
    Seeman P
    Neuropsychopharmacology; 1992 Dec; 7(4):261-84. PubMed ID: 1362057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical characteristics of D1 dopamine receptors: relationship to behavior and schizophrenia.
    Creese I; Hess EJ
    Clin Neuropharmacol; 1986; 9 Suppl 4():14-6. PubMed ID: 2882838
    [No Abstract]   [Full Text] [Related]  

  • 14. Structural analogs of SCH 23390 as discriminators of dopamine receptor subtypes: behavioral interactions between D-1 and D-2 agonists and antagonists.
    O'Boyle KM; Molloy AG; Mashurano M; Waddington JL
    Psychopharmacol Bull; 1986; 22(3):599-604. PubMed ID: 2879303
    [No Abstract]   [Full Text] [Related]  

  • 15. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics.
    Sokoloff P; Giros B; Martres MP; Bouthenet ML; Schwartz JC
    Nature; 1990 Sep; 347(6289):146-51. PubMed ID: 1975644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical neuroleptic drugs downregulate dopamine sensitivity in rat cortical and striatal astrocytes.
    Reuss B; Unsicker K
    Mol Cell Neurosci; 2001 Aug; 18(2):197-209. PubMed ID: 11520180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D1 and D2 and D3.
    Healy D
    Br J Psychiatry; 1991 Sep; 159():319-24. PubMed ID: 1683592
    [No Abstract]   [Full Text] [Related]  

  • 18. The dopamine D3 receptor as a key target for antipsychotics.
    Sokoloff P; Levesque D; Martres MP; Lannfelt L; Diaz G; Pilon C; Schwartz JC
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():456A-457A. PubMed ID: 1354048
    [No Abstract]   [Full Text] [Related]  

  • 19. Differential development of therapeutic drugs for psychosis.
    Lewander T
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():654A-655A. PubMed ID: 1354072
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of dopamine D1 and D2 receptors in mediating the d-amphetamine discriminative cue.
    Furmidge LJ; Exner M; Clark D
    Eur J Pharmacol; 1991 Sep; 202(2):191-9. PubMed ID: 1687032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.